2015
DOI: 10.1016/j.neubiorev.2015.03.012
|View full text |Cite
|
Sign up to set email alerts
|

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use

Abstract: Misuse of gamma hydroxybutrate (GHB) and gamma butyrolactone (GBL) has increased greatly since the early 1990s, being implicated in a rising number of deaths. This paper reviews knowledge on GHB and derivatives, and explores the largest series of deaths associated with their non-medical use. Descriptive analyses of cases associated with GHB/GBL and 1,4-butanediol (1,4-BD) use extracted from the UK's National Programme on Substance Abuse Deaths database. From 1995 to September 2013, 159 GHB/GBL-associated fatal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
62
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 87 publications
(66 citation statements)
references
References 224 publications
(223 reference statements)
3
62
1
Order By: Relevance
“…Toxicological analysis in nonfatal cases showed a mean GHB concentration of 245 mg/L (range, 86–551 mg/L; n  = 20) in one small study [35], a median GHB concentration of 180 mg/L (range, 45–295 mg/L; n  = 15) in another study [36], and a mean GHB concentration of 137 mg/L (median, 103 mg/L; range, 29–490 mg/L; n  = 54) in a larger study [18]. Published reports of GHB-related fatalities show a wide range of concentrations that are measured in postmortem blood (0-6500 mg/L) [17, 33, 37, 38], with a median concentration of 190–347 mg/L [17, 33, 37], mean ± SD concentration of 482 ± 758 mg/L [38], and concentration of 300 mg/L that is suggested to be sufficient to cause death [37]. Thus, the concentrations of GHB in survivors and non-survivors seem to overlap.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Toxicological analysis in nonfatal cases showed a mean GHB concentration of 245 mg/L (range, 86–551 mg/L; n  = 20) in one small study [35], a median GHB concentration of 180 mg/L (range, 45–295 mg/L; n  = 15) in another study [36], and a mean GHB concentration of 137 mg/L (median, 103 mg/L; range, 29–490 mg/L; n  = 54) in a larger study [18]. Published reports of GHB-related fatalities show a wide range of concentrations that are measured in postmortem blood (0-6500 mg/L) [17, 33, 37, 38], with a median concentration of 190–347 mg/L [17, 33, 37], mean ± SD concentration of 482 ± 758 mg/L [38], and concentration of 300 mg/L that is suggested to be sufficient to cause death [37]. Thus, the concentrations of GHB in survivors and non-survivors seem to overlap.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the concentrations of GHB in survivors and non-survivors seem to overlap. However, the possible production and redistribution of GHB after death (depending on the methodology, concentrations up to 197 mg/L even in cases without GHB ingestion [38]) and several other factors (e.g., elapsed time from ingestion to death and from death to sample collection and testing; methods of sample storage and analysis; different levels based on sampling site; the occurrence of delayed death at low GHB concentrations because of loss of consciousness, hypoventilation, and hypoxia [1, 33, 38]; and the possibility that other substances are the cause of death in polyintoxication cases) make the interpretation of postmortem GHB concentrations difficult, with no clearly defined “lethal” concentration [33]. The measured concentrations in our study (median, 240 mg/L; range, 8.3–373 mg/L) were similar to those reported in the other non-fatal GHB intoxication cases.…”
Section: Discussionmentioning
confidence: 99%
“…However, when given under medical supervision in specific indications like narcolepsy, alcohol dependence and withdrawal, but also in experimental animals for more than 8 months daily, GHB exhibited no chronic toxicity except dependence and withdrawal disturbances in some patients or animals . GHB is also a recreational drug of abuse because of its easy availability, synthesis, and low cost with a reported high acute toxicity and mortality rate in medical and forensic publications . It is also considered as a “date‐rape” substance, like many sedative‐hypnotics compounds that target GABA receptors (especially GABA‐A receptors).…”
Section: The Endogenous Ghb System In Brainmentioning
confidence: 99%
“…GHB, a potent central nervous system neuromodulator with a biphasic pharmacological profile of stimulant in lower doses and depressant in higher ones, is quite commonly encountered during forensic examination of living and deceased subjects in music and sex settings . In addition, not only GHB, but also its two precursors GBL and 1,4‐butanediol (1,4‐BD) have been implicated in a rising number of severe intoxications and deaths …”
Section: Resultsmentioning
confidence: 99%